Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1986 Feb;21(2):143–148. doi: 10.1111/j.1365-2125.1986.tb05168.x

Effect of captopril on bradykinin inactivation by human foetal placental circulation.

R Soares de Moura, N Solano Vale
PMCID: PMC1400901  PMID: 3513809

Abstract

The inactivation of bradykinin on passage across the human foetal placental circulation was investigated in six full-term human placentas. The placentas were perfused with a modified Krebs-Henseleit solution and placenta perfusion pressure was recorded. Samples collected at the arterial inflow and at the venous effluent were assayed on the isolated guinea-pig ileum as an estimation of bradykinin activity. Bradykinin (100 ng ml-1) was infused through the foetal placental vessels before and during captopril 4 X 10(-7) M. Bradykinin produced a transient increase in placental vascular resistance that was not potentiated by captopril. Bradykinin activity was completely abolished after passage through the foetal placental circulation, and the inactivation was blocked by captopril. These data suggest that angiotensin I converting enzyme (kininase II) might occur in the foetal placental vessels.

Full text

PDF
143

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abramovich D. R., Page K. R., Wright F. Effect of angiotensin II and 5-hydroxytryptamine on the vessels of the human foetal cotyledon. Br J Pharmacol. 1983 May;79(1):53–56. doi: 10.1111/j.1476-5381.1983.tb10494.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Altura B. M., Malaviya D., Reich C. F., Orkin L. R. Effects of vasoactive agents on isolated human umbilical arteries and veins. Am J Physiol. 1972 Feb;222(2):345–355. doi: 10.1152/ajplegacy.1972.222.2.345. [DOI] [PubMed] [Google Scholar]
  3. BROWN J. J., DAVIES D. L., DOAK P. B., LEVER A. F., ROBERTSON J. I. PLASMA-RENIN IN NORMALPREGNANCY. Lancet. 1963 Nov 2;2(7314):900–901. doi: 10.1016/s0140-6736(63)90614-7. [DOI] [PubMed] [Google Scholar]
  4. Baljet B., Drukker J. Some aspects of the innervation of the abdominal and pelvic organs in the human female fetus. Acta Anat (Basel) 1982;111(3):222–230. doi: 10.1159/000145470. [DOI] [PubMed] [Google Scholar]
  5. Broughton Pipkin F., O'Brien P. M. Effect of the specific angiotensin antagonist (Sar1) (Ala8) angiotensin II on blood pressure and the renin-angiotensin system in the conscious pregnant ewe and fetus. Am J Obstet Gynecol. 1978 Sep 1;132(1):7–15. doi: 10.1016/0002-9378(78)90790-1. [DOI] [PubMed] [Google Scholar]
  6. Broughton Pipkin F., Symonds E. M. Factors affecting angiotensin II concentrations in the human infant at birth. Clin Sci Mol Med. 1977 May;52(5):449–456. doi: 10.1042/cs0520449. [DOI] [PubMed] [Google Scholar]
  7. Erdös E. G. Angiotensin I converting enzyme. Circ Res. 1975 Feb;36(2):247–255. doi: 10.1161/01.res.36.2.247. [DOI] [PubMed] [Google Scholar]
  8. Gaudreau P., Barabé J., St-Pierre S., Regoli D. Pharmacological studies of kinins in venous smooth muscles. Can J Physiol Pharmacol. 1981 Apr;59(4):371–379. doi: 10.1139/y81-059. [DOI] [PubMed] [Google Scholar]
  9. Gulati O. D., Parikh H., Umar M. S. Receptors for noradrenaline and histamine in the rabbit's posterior vena cava. Br J Pharmacol Chemother. 1968 Jan;32(1):87–95. doi: 10.1111/j.1476-5381.1968.tb00432.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hébert F., Fouron J. C., Boileau J. C., Biron P. Pulmonary fate of vasoactive peptides in fetal, newborn, and adult sheep. Am J Physiol. 1972 Jul;223(1):20–23. doi: 10.1152/ajplegacy.1972.223.1.20. [DOI] [PubMed] [Google Scholar]
  11. Limas C. J. Selective stimulation of venous prostaglandin E 9-ketoreductase by bradykinin. Biochim Biophys Acta. 1977 Jul 21;498(1):306–315. doi: 10.1016/0304-4165(77)90268-9. [DOI] [PubMed] [Google Scholar]
  12. Melmon K. L., Cline M. J., Hughes T., Nies A. S. Kinins: possible mediators of neonatal circulatory changes in man. J Clin Invest. 1968 Jun;47(6):1295–1302. doi: 10.1172/JCI105821. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Rudolph A. M., Heymann M. A. Circulatory changes during growth in the fetal lamb. Circ Res. 1970 Mar;26(3):289–299. doi: 10.1161/01.res.26.3.289. [DOI] [PubMed] [Google Scholar]
  14. Soveri P., Fyhrquist F., Widholm O. Plasma renin activity in maternal and umbilical cord blood during parturition. Am J Obstet Gynecol. 1975 Feb 15;121(4):559–562. doi: 10.1016/0002-9378(75)90092-7. [DOI] [PubMed] [Google Scholar]
  15. Stalcup S. A., Pang L. M., Lipset J. S., Odya C. E., Goodfriend T. L., Mellins R. B. Gestational changes in pulmonary converting enzyme activity in the fetal rabbit. Circ Res. 1978 Nov;43(5):705–711. doi: 10.1161/01.res.43.5.705. [DOI] [PubMed] [Google Scholar]
  16. Tetlow H. J., Broughton Pipkin F. Studies on the effect of mode of delivery on the renin-angiotensin system in mother and fetus at term. Br J Obstet Gynaecol. 1983 Mar;90(3):220–226. doi: 10.1111/j.1471-0528.1983.tb08612.x. [DOI] [PubMed] [Google Scholar]
  17. Toda N. Actions of bradykinin on isolated cerebral and peripheral arteries. Am J Physiol. 1977 Mar;232(3):H267–H274. doi: 10.1152/ajpheart.1977.232.3.H267. [DOI] [PubMed] [Google Scholar]
  18. Tulenko T. N. Regional sensitivity to vasoactive polypeptides in the human umbilicoplacental vasculature. Am J Obstet Gynecol. 1979 Nov 1;135(5):629–636. doi: 10.1016/s0002-9378(16)32988-x. [DOI] [PubMed] [Google Scholar]
  19. Vane J. R. The release and fate of vaso-active hormones in the circulation. Br J Pharmacol. 1969 Feb;35(2):209–242. doi: 10.1111/j.1476-5381.1969.tb07982.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Wigger H. J., Stalcup S. A. Distribution and development of angiotensin converting enzyme in the fetal and newborn rabbit. An immunofluorescence study. Lab Invest. 1978 May;38(5):581–585. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES